BCTX logo

BriaCell Therapeutics (BCTX)

Profile

Full Name

BriaCell Therapeutics Corp.

Ticker Symbol

BCTX

Exchange

NASDAQ

Country

Canada

IPO

March 14, 2012

Indexes

Not included

Employees

16

Key Details

Price

$3.75(-14.38%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$4.35(+77.69% YoY)

PE ratio

-

Next earnings date

Jun 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Feb 3, 25 HC Wainwright & Co.
Buy
Dec 12, 24 HC Wainwright & Co.
Buy
Dec 3, 24 HC Wainwright & Co.
Buy
Oct 3, 24 HC Wainwright & Co.
Buy
Sep 19, 24 HC Wainwright & Co.
Buy
Sep 11, 24 HC Wainwright & Co.
Buy
Jun 4, 24 HC Wainwright & Co.
Buy
May 24, 24 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for BriaCell Therapeutics?
  • Does BriaCell Therapeutics pay dividends?
  • What sector is BriaCell Therapeutics in?
  • What industry is BriaCell Therapeutics in?
  • What country is BriaCell Therapeutics based in?
  • When did BriaCell Therapeutics go public?
  • Is BriaCell Therapeutics in the S&P 500?
  • Is BriaCell Therapeutics in the NASDAQ 100?
  • Is BriaCell Therapeutics in the Dow Jones?
  • When was BriaCell Therapeutics's last earnings report?
  • When does BriaCell Therapeutics report earnings?
  • Should I buy BriaCell Therapeutics stock now?

What is the ticker symbol for BriaCell Therapeutics?

The ticker symbol for BriaCell Therapeutics is NASDAQ:BCTX

Does BriaCell Therapeutics pay dividends?

No, BriaCell Therapeutics does not pay dividends

What sector is BriaCell Therapeutics in?

BriaCell Therapeutics is in the Healthcare sector

What industry is BriaCell Therapeutics in?

BriaCell Therapeutics is in the Biotechnology industry

What country is BriaCell Therapeutics based in?

BriaCell Therapeutics is headquartered in Canada

When did BriaCell Therapeutics go public?

BriaCell Therapeutics's initial public offering (IPO) was on March 14, 2012

Is BriaCell Therapeutics in the S&P 500?

No, BriaCell Therapeutics is not included in the S&P 500 index

Is BriaCell Therapeutics in the NASDAQ 100?

No, BriaCell Therapeutics is not included in the NASDAQ 100 index

Is BriaCell Therapeutics in the Dow Jones?

No, BriaCell Therapeutics is not included in the Dow Jones index

When was BriaCell Therapeutics's last earnings report?

BriaCell Therapeutics's most recent earnings report was on Jun 14, 2024

When does BriaCell Therapeutics report earnings?

The next expected earnings date for BriaCell Therapeutics is Jun 13, 2025

Should I buy BriaCell Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page